@Starlink your post is completely delusional. You need to write this down 100 times.
‘Viraleze™ reduced viral load in the full study population including all patient age groups (N=197), although the difference vs placebo was not statistically significant’ ~Starpharma
- Forums
- ASX - By Stock
- SPL
- Tough start for the new CEO
Tough start for the new CEO, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $41.39M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.9¢ | $23.28K | 232.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 183364 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.099 |
1 | 150000 | 0.098 |
1 | 75000 | 0.097 |
2 | 51927 | 0.096 |
1 | 824859 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 183364 | 5 |
0.110 | 204944 | 7 |
0.115 | 59827 | 2 |
0.120 | 201197 | 5 |
0.125 | 30000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online